Page last updated: 2024-08-16

ribavirin and 2019 Novel Coronavirus Disease

ribavirin has been researched along with 2019 Novel Coronavirus Disease in 70 studies

Research

Studies (70)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	70 (100.00)	2.80

Authors

Authors	Studies
Agard, DA; Ashworth, A; Barrio-Hernandez, I; Batra, J; Beltrao, P; Bennett, MJ; Bohn, M; Bouhaddou, M; Braberg, H; Broadhurst, DJ; Cai, Y; Cakir, M; Calviello, L; Cavero, DA; Chang, JCJ; Chorba, JS; Craik, CS; d'Enfert, C; Dai, SA; Eckhardt, M; Emerman, M; Fabius, JM; Fletcher, SJ; Floor, SN; Foussard, H; Frankel, AD; Fraser, JS; Fujimori, DG; Ganesan, SJ; García-Sastre, A; Gordon, DE; Gross, JD; Guo, JZ; Haas, K; Haas, P; Hernandez-Armenta, C; Hiatt, J; Huang, XP; Hubert, M; Hüttenhain, R; Ideker, T; Jacobson, M; Jang, GM; Jura, N; Kaake, RM; Kim, M; Kirby, IT; Klippsten, S; Koh, C; Kortemme, T; Krogan, NJ; Kuzuoglu-Ozturk, D; Li, Q; Liboy-Lugo, J; Lin, Y; Liu, X; Liu, Y; Lou, K; Lyu, J; Mac Kain, A; Malik, HS; Mathy, CJP; McGregor, MJ; Melnyk, JE; Memon, D; Meyer, B; Miorin, L; Modak, M; Moreno, E; Mukherjee, S; Naing, ZZC; Noack, J; O'Meara, MJ; O'Neal, MC; Obernier, K; Ott, M; Peng, S; Perica, T; Pilla, KB; Polacco, BJ; Rakesh, R; Rathore, U; Rezelj, VV; Richards, AL; Roesch, F; Rosenberg, OS; Rosenthal, SB; Roth, BL; Roth, TL; Ruggero, D; Safari, M; Sali, A; Saltzberg, DJ; Savar, NS; Schwartz, O; Sharp, PP; Shen, W; Shengjuler, D; Shi, Y; Shoichet, BK; Shokat, KM; Soucheray, M; Stroud, RM; Subramanian, A; Swaney, DL; Taunton, J; Tran, QD; Trenker, R; Tummino, TA; Tutuncuoglu, B; Ugur, FS; Vallet, T; Venkataramanan, S; Verba, KA; Verdin, E; Vignuzzi, M; von Zastrow, M; Wang, HY; Wankowicz, SA; Wenzell, NA; White, KM; Xu, J; Young, JM; Zhang, Z; Zhou, Y	1
Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X	1
Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL	1
Ahamad, S; Branch, S; Harrelson, S; Hussain, MK; Khan, S; Saquib, M	1
Assis, LC; da Cunha, EFF; de Almeida La Porta, F; de Castro Ramalho, T; de Castro, AA; de Jesus, JPA; Kuca, K; Nepovimova, E	1
Chiappini, E; de Martino, M; Galli, L; Motisi, MA; Parigi, S; Tamborino, A	1
Chen, S; Duan, G; Ji, W; Jin, Y; Zhang, W; Zhang, Y	1
Christensen, PB; Dröse, S; Hansen, JF; Holm, DK; Madsen, LW; Røge, BT; Øvrehus, A	1
Biswas, A; Fiches, GN; Kenney, AD; Li, TW; Liu, H; Martinez-Sobrido, L; Park, JG; Que, J; Santoso, N; Yount, JS; Zhao, W; Zhou, D; Zhu, J	1
Bearne, SL; Gillis, TD	1
Bacci, MR; Barakat, M; Israel, RJ; Poulakou, G	1
de Ávila, AI; Domingo, E; Durán-Pastor, A; Enjuanes, L; Esteban, J; Esteban-Muñoz, M; Fernandez-Roblas, R; Ferrer-Orta, C; Gadea, I; Gallego, I; García-Crespo, C; Gómez, J; Martínez-González, B; Mínguez, P; Perales, C; Salar-Vidal, L; Sola, I; Somovilla, P; Soria, ME; Verdaguer, N; Zuñiga, S	1
Guo, Z; He, H; Huang, B; Lai, C; Li, Z; Liao, Z; Liu, K; Pan, X; Ren, X; Yang, S	1
Elfiky, AA	1
Chen, YK; Harypursat, V; He, XQ; Huang, YQ; Li, Y; Tang, SQ; Xu, XL; Zeng, YM	1
Martinez, MA	2
Wang, Y; Zhu, LQ	1
Dai, Y; Huang, S; Zhang, C; Zheng, F	1
Cai, C; Cui, X; Guo, W; He, S; Wang, J; Xu, Y; Zhang, T; Zhao, X; Zheng, G; Zheng, J	1
Khalili, JS; Mak, NSA; Yan, Y; Zhu, H; Zhu, Y	1
Chan, MCW; Chen, D; Cheung, PP; Choy, KT; Chu, DKW; Huang, X; Hui, KPY; Kaewpreedee, P; Peiris, M; Sia, SF; Wong, AY; Yen, HL	1
Barlow, A; Barlow, B; Claassen, CW; Heavner, JJ; Heavner, MS; Landolf, KM; Yeung, SYA	1
Chen, L; Chen, M; Huang, T; Huang, Z; Liu, L; Liu, M; Qiao, K; Wang, J; Xin, N; Zhang, G; Zhang, Z	1
Cutrell, JB; Jodlowski, TZ; Monogue, ML; Sanders, JM	1
Chen, CP; Cheng, CY; Cheng, SH; Lee, YL; Liao, CH; Lin, YC; Liu, CE	1
Wan, Y; Wang, D; Wu, F; Zhang, L; Zhang, W	1
Chan, JMC; Chik, TSH; Choi, CYC; Lau, AWT; Lau, DPL; Leung, WS; Tsang, OTY	1
Shalhoub, S	1
Chan, J; Chan, JF; Chan, JW; Chan, KH; Chan, V; Chan, WM; Cheng, VC; Chu, AW; Chu, MY; Chung, TW; Fung, AY; Fung, K; Hung, IF; Ip, JD; Lau, CS; Law, WL; Lee, R; Leung, KH; Leung, WS; Lie, AK; Liu, R; Lo, J; Lung, DC; Lung, KC; Ng, AC; Ng, YY; Que, TL; Shum, HP; Sin, KM; Sin, S; Tam, AR; To, KK; Tsang, OT; Tso, EY; Wu, AK; Wu, TC; Yan, EY; Yan, WW; Yeung, A; Yeung, P; Yip, CC; Yuen, KY; Zhang, RR	1
Gao, P; Liu, M; Peng, H; Peng, J; Wang, Y; Xu, H; Xu, Q	1
He, J; Huang, D; Li, J; Liang, W; Liu, L; Xia, Z; Xu, X; Zhao, Y	1
Cheng, GS; Kicska, GA; Kinahan, PE; Li, T; Liu, L; Pipavath, SNJ; Wu, W	1
Chen, K; Couban, RJ; Du, X; Gong, X; Guyatt, G; He, N; Ibrahim, QI; Li, X; Li, Y; Liu, F; Liu, J; Liu, W; Shen, N; Tang, Q; Wu, Z; Xu, X; Ye, Z; Ying, Y; Zhai, S; Zhang, Q; Zhang, Y; Zhou, P	1
Amore, A; Bimonte, S; Cascella, M; Celentano, E; Crispo, A; Cuomo, A	1
Almasri, H; Ata, F; Sajid, J; Yousaf, Z	1
Bai, K; Chen, H; Fu, Y; Hu, J; Li, C; Liu, C; Liu, W; Qin, Y; Xu, F; Zhang, Q	1
Chen, D; Dong, L; Pan, X; Peng, C; Yang, L	1
Li, C; Ren, L; Wang, L	1
Chan, HL; Chow, VC; Ho, TH; Hui, DS; Li, TC; Lui, GC; Tse, YK; Wong, GL; Wong, VW; Yip, TC	1
He, K; Jia, Z; Shi, J; Song, X; Wang, W	1
Li, Z; Liu, Y; Wang, D	1
Carvalho Junior, RN; J C Neto, AM; Martins, AY; Reis, AF; S Costa, JF; Silva Arouche, TD	1
Chen, J; Jiang, J; Su, Y; Tong, S; Wang, S; Wu, C; Yu, Y	1
Gan, W; Gu, J; Li, H; Li, Y; Lu, C; Luo, P; Miao, H; Tian, M; Wang, J; Wang, S; Wu, M; Yao, Y; Yuan, B; Zhao, D; Zhao, X	1
Cai, ZB; Chen, C; Huang, JS; Liu, F; Liu, Y; Niu, HY; Xu, AF; Yan, TB; Yu, WY; Zhang, Y	1
Abbaspour Kasgari, H; Alikhani, A; Babamahmoodi, F; Davoudi Badabi, AR; Davoudi, L; Garratt, A; Hedayatizadeh Omran, A; Hill, A; Levi, J; Merat, S; Moradi, S; Saeedi, M; Shabani, AM; Simmons, B; Tirgar Fakheri, H; Wentzel, H	1
Bitaraf, S; Eslami, G; Esmaeilian, H; Freeman, J; Hajizadeh Farsani, M; Hill, A; Jafari Kashi, AH; Jelvay, S; Lotfi, Z; Marjani, S; Mobarak, M; Mobarak, S; Momtazan, M; Mousaviasl, S; Radmanesh, E; Sadeghi, A; Salmanzadeh, S; Simmons, B; Tabibi, R; Talebzadeh, SM; Wentzel, H; Wickramatillake, A	1
Brown, F; Cotton, MF; Decloedt, EH; Dodds, MG; Dron, L; Mills, EJ; Niranjan, V; Park, JJH; Rayner, CR; Reis, G; Smith, PF; Wesche, D	1
Gorczyńska, E; Jarmoliński, T; Kałwak, K; Matkowska-Kocjan, A; Olejnik, I; Rosa, M; Ussowicz, M	1
Jiang, Z; Li, W; Wang, Y; Xi, X; Zhu, Y	1
Hong, D; Shan, W; Zhao, Q; Zhu, J	1
Baroutjian, A; Boneva, D; Elkbuli, A; McKenney, M; Sanchez, C	1
Bahurupi, YA; Bandyopadhyay, A; Chikara, G; Moirangthem, B; Panda, PK; Saha, S; Singh, BC	1
Dunning, J; Ison, M; Lee, N	1
Hung, IF; Yuen, KY	1
Islam, MA; Nasir, M; Perveen, RA; Selina, F; Talha, KA	1
Albreem, MA; Alomari, OA; Alsharif, MH; Alsharif, YH; Hossain, MS; Jahid, A; Solyman, AAA; Yahya, K	1
Chen, X; Huang, Z; Kuang, Y; Liu, C; Liu, P; Pan, P; Yin, M	1
Ghorat, F; Kalan Farmanfarma, K; Mahdavifar, N; Moslem, A; Nematshahi, M; Salehiniya, H	1
Govil, A; Luckett, K; Miller-Handley, H	1
Falk, A; Helleday, T; Mirazimi, A; Pettke, A; Pronk, R; Puumalainen, MR; Tampere, M; Wallner, O; Warpman Berglund, U	1
Wen, S; Xu, X; Yadav, AK; Yu, L	1
Gong, Y; Jiang, N; Li, C; Li, H; Liu, L; Lu, Z; Tan, X; Wang, J; Xiong, N; Yang, H; Yin, X; Zong, Q	1
Danduga, RCSR; James, RA; Kandaswamy, DK; Raj, CTD; Rajasabapathy, R	1
Aussel, L; Corteggiani, M; Gombert, L; Pellegri, C	1
Kamimura, H; Kamimura, K; Terai, S; Tsuchiya, A	1
Aghajani, F; Akhavizadegan, H; Dolatkhani, F; Faghir Gangi, M; Ghasemi, H; Ghazi, Z; Mousavi Movahed, SM; Nejadghaderi, SA	1
Briones, C; de Ávila, AI; Domingo, E; Gallego, I; García-Crespo, C; Gómez, J; Gregori, J; Lobo-Vega, R; Martínez-González, B; Moreno, E; Perales, C; Quer, J; Soria, ME; Vázquez-Sirvent, L	1
Anedda, L; Bianchini, L; Cuzzolin, L; Fanos, V; Finco, G; Marcialis, MA	1

Reviews

25 review(s) available for ribavirin and 2019 Novel Coronavirus Disease

Article	Year
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Journal of medicinal chemistry, 2020, 11-25, Volume: 63, Issue:22 Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries	2020
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective. Medicinal research reviews, 2021, Volume: 41, Issue:1 Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization	2021
Primed for global coronavirus pandemic: Emerging research and clinical outcome. European journal of medicinal chemistry, 2021, Jan-01, Volume: 209 Topics: Antiviral Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Drug Repositioning; Humans; Pandemics; SARS-CoV-2	2021
An Update on Innate Immune Responses during SARS-CoV-2 Infection. Viruses, 2021, 10-14, Volume: 13, Issue:10 Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cytokines; Drug Combinations; Humans; Immune Evasion; Immunity, Innate; Interferon Type I; Lopinavir; Ribavirin; Ritonavir; SARS-CoV-2; Signal Transduction	2021
Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus. Antimicrobial agents and chemotherapy, 2020, 04-21, Volume: 64, Issue:5 Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Immunization, Passive; Interferon-beta; Lopinavir; Mice, Transgenic; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; Ribavirin; Ritonavir; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus	2020
Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019. World journal of pediatrics : WJP, 2020, Volume: 16, Issue:3 Topics: Adolescent; Age Factors; Antiviral Agents; Child; Child, Preschool; China; Chloroquine; Coronavirus Infections; COVID-19; Female; Humans; Indoles; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Male; Pandemics; Pharmaceutical Services; Pneumonia, Viral; Practice Guidelines as Topic; Prognosis; Ribavirin; Risk Assessment; Severe Acute Respiratory Syndrome; Treatment Outcome	2020
Controversial treatments: An updated understanding of the coronavirus disease 2019. Journal of medical virology, 2020, Volume: 92, Issue:9 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Extracorporeal Membrane Oxygenation; Glucocorticoids; Humans; Liver, Artificial; Ribavirin	2020
Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19. Journal of medical virology, 2020, Volume: 92, Issue:7 Topics: Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Disease Progression; Drug Administration Schedule; Gene Expression Regulation, Viral; Humans; Pandemics; Pneumonia, Viral; Ribavirin; RNA, Viral; SARS-CoV-2; Signal Transduction	2020
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019. Pharmacotherapy, 2020, Volume: 40, Issue:5 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunomodulation; Interferon-alpha; Lopinavir; Nelfinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Ribavirin; Ritonavir; SARS-CoV-2; Sulfonamides; Thiazoles	2020
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA, 2020, May-12, Volume: 323, Issue:18 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulins; Immunologic Factors; Indoles; Lopinavir; Oseltamivir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Withholding Treatment	2020
Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2020, 07-06, Volume: 192, Issue:27 Topics: Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Evidence-Based Medicine; Humans; Hydroxychloroquine; Indoles; Influenza, Human; Lopinavir; Observational Studies as Topic; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2	2020
Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research. In vivo (Athens, Greece), 2020, Volume: 34, Issue:3 Suppl Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Drugs, Investigational; Humans; Indoles; Lopinavir; Multicenter Studies as Topic; Neuraminidase; Pandemics; Pneumonia, Viral; Primates; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome	2020
Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China. Virus research, 2020, Volume: 286 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Humans; Indoles; Interferons; Lopinavir; Lung; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis	2020
Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection. Virus research, 2020, Volume: 286 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Drug Combinations; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Indoles; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis; Teicoplanin	2020
Clinical Trials of Repurposed Antivirals for SARS-CoV-2. Antimicrobial agents and chemotherapy, 2020, 08-20, Volume: 64, Issue:9 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Combinations; Drug Repositioning; Humans; Hydroxychloroquine; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Randomized Controlled Trials as Topic; Ribavirin; Ritonavir; SARS-CoV-2; Survival Analysis; Treatment Outcome	2020
An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics. Journal of infection and public health, 2020, Volume: 13, Issue:10 Topics: Adenosine Monophosphate; Alanine; Amides; Angiotensin-Converting Enzyme Inhibitors; Antimalarials; Antiviral Agents; Betacoronavirus; Biomedical Research; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Combinations; Drug Development; Drugs, Chinese Herbal; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2	2020
Update on recommendations for the diagnosis and treatment of SARS-CoV-2 infection in children. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:12 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Asymptomatic Diseases; Betacoronavirus; Biomarkers; Child; Clinical Laboratory Techniques; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Drug Combinations; Early Diagnosis; Fever; Humans; Hydroxychloroquine; Interferon-alpha; Lopinavir; Pandemics; Pneumonia, Viral; Practice Guidelines as Topic; Ribavirin; Ritonavir; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed	2020
SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence. The American journal of emergency medicine, 2020, Volume: 38, Issue:11 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Combinations; Evidence-Based Medicine; Humans; Hydroxychloroquine; Interferon beta-1b; Lopinavir; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Ribavirin; Ritonavir; Systematic Reviews as Topic	2020
Systematic review on current antiviral therapy in COVID-19 pandemic. The Medical journal of Malaysia, 2020, Volume: 75, Issue:6 Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Ribavirin; SARS-CoV-2	2020
Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:22 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Artificial Intelligence; Ascorbic Acid; Chloroquine; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Deep Learning; Drug Combinations; Drug Development; Drug Repositioning; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lopinavir; Machine Learning; Ribavirin; Ritonavir; Vitamins	2020
Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function. Advances in chronic kidney disease, 2020, Volume: 27, Issue:5 Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Creatinine; Cytidine; Dexamethasone; Drug Combinations; Drug Interactions; Humans; Hydroxychloroquine; Hydroxylamines; Immunization, Passive; Interferons; Janus Kinase Inhibitors; Lopinavir; Pyrazines; Renal Elimination; Renal Insufficiency, Chronic; Renal Replacement Therapy; Ribavirin; Ritonavir; SARS-CoV-2	2020
Antiviral treatment in COVID-19: which is the most promising?-a narrative review. Annals of palliative medicine, 2021, Volume: 10, Issue:1 Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles	2021
COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics-a review. Archives of microbiology, 2021, Volume: 203, Issue:5 Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Serotherapy; Dexamethasone; Drug Repositioning; Evolution, Molecular; Humans; Hydroxychloroquine; Immunization, Passive; Lopinavir; Pandemics; Phylogeny; Prospective Studies; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2	2021
Population Disequilibrium as Promoter of Adaptive Explorations in Hepatitis C Virus. Viruses, 2021, 04-03, Volume: 13, Issue:4 Topics: Antiviral Agents; Cell Line; COVID-19; Drug Resistance, Viral; Hepacivirus; Hepatitis C; Humans; Mutation; Ribavirin; RNA, Viral; Sequence Analysis; Viral Nonstructural Proteins; Virus Replication	2021
What if COVID-19 affects the child: which weapons and how to use them. European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:8 Topics: Adenosine Monophosphate; Adolescent; Age Factors; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Carrier State; Child; Child, Preschool; Chloroquine; Continuous Renal Replacement Therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Extracorporeal Membrane Oxygenation; Glucocorticoids; Humans; Hydroxychloroquine; Immunization, Passive; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Oseltamivir; Receptors, Cell Surface; Respiration, Artificial; Ribavirin; Ritonavir; SARS-CoV-2; Severity of Illness Index; Thrombosis	2021

Trials

7 trial(s) available for ribavirin and 2019 Novel Coronavirus Disease

Article	Year
Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin-A Randomized Controlled Clinical Trial. Viruses, 2022, 03-16, Volume: 14, Issue:3 Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; COVID-19; Cyclopropanes; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Pandemics; Proline; Pyrrolidines; Quinoxalines; Ribavirin; Sulfonamides	2022
Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protoc Chinese medical journal, 2020, May-05, Volume: 133, Issue:9 Topics: Adult; Aged; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Interferon-alpha; Lopinavir; Middle Aged; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Ribavirin; Ritonavir; SARS-CoV-2	2020
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet (London, England), 2020, 05-30, Volume: 395, Issue:10238 Topics: Adult; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hong Kong; Hospitalization; Humans; Interferon beta-1b; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Ribavirin; Ritonavir; SARS-CoV-2	2020
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial. The Journal of antimicrobial chemotherapy, 2020, 11-01, Volume: 75, Issue:11 Topics: Adult; Aged; Antiviral Agents; Betacoronavirus; Carbamates; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Female; Hospitalization; Humans; Imidazoles; Iran; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pyrrolidines; Ribavirin; SARS-CoV-2; Sofosbuvir; Treatment Outcome; Valine	2020
The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19. The Journal of antimicrobial chemotherapy, 2020, 11-01, Volume: 75, Issue:11 Topics: Adult; Aged; Antiviral Agents; Betacoronavirus; Carbamates; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Female; Humans; Imidazoles; Male; Middle Aged; Pandemics; Pneumonia, Viral; Pyrrolidines; Ribavirin; SARS-CoV-2; Sofosbuvir; Treatment Outcome; Valine	2020
Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial. Trials, 2020, Oct-20, Volume: 21, Issue:1 Topics: Administration, Oral; Adult; Antimalarials; Antiviral Agents; Betacoronavirus; Clinical Protocols; Combined Modality Therapy; Coronavirus Infections; COVID-19; Cytochrome P-450 CYP3A Inhibitors; Female; Humans; Hydroxychloroquine; India; Informed Consent; Lopinavir; Male; Pandemics; Pneumonia, Viral; Ribavirin; Ritonavir; Safety; SARS-CoV-2; Time Factors; Treatment Outcome	2020
Safety and Efficacy of Ixekizumab and Antiviral Treatment for Patients with COVID-19: A structured summary of a study protocol for a Pilot Randomized Controlled Trial. Trials, 2020, Dec-04, Volume: 21, Issue:1 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antimalarials; Antiviral Agents; Case-Control Studies; China; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Indoles; Interleukin-17; Lopinavir; Middle Aged; Ribavirin; Ritonavir; Safety; SARS-CoV-2; Th17 Cells; Treatment Outcome	2020

Other Studies

38 other study(ies) available for ribavirin and 2019 Novel Coronavirus Disease

Article	Year
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature, 2020, Volume: 583, Issue:7816 Topics: Animals; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Cloning, Molecular; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; HEK293 Cells; Host-Pathogen Interactions; Humans; Immunity, Innate; Mass Spectrometry; Molecular Targeted Therapy; Pandemics; Pneumonia, Viral; Protein Binding; Protein Biosynthesis; Protein Domains; Protein Interaction Mapping; Protein Interaction Maps; Receptors, sigma; SARS-CoV-2; SKP Cullin F-Box Protein Ligases; Vero Cells; Viral Proteins	2020
Effect of drug metabolism in the treatment of SARS-CoV-2 from an entirely computational perspective. Scientific reports, 2021, 10-07, Volume: 11, Issue:1 Topics: Adenine; Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Drug Design; Drug Discovery; Humans; Metabolic Networks and Pathways; Molecular Docking Simulation; Nitro Compounds; Pyrazines; Pyrrolidines; Ribavirin; SARS-CoV-2; Thiazoles	2021
The use of antiviral drugs in children. Journal of chemotherapy (Florence, Italy), 2022, Volume: 34, Issue:2 Topics: Adult; Antiviral Agents; Child; COVID-19; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Infant, Newborn; Ribavirin; SARS-CoV-2	2022
SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling. Frontiers in immunology, 2022, Volume: 13 Topics: Bortezomib; COVID-19; Cytokines; Exoribonucleases; Humans; IMP Dehydrogenase; Inosine; Interleukin-6; Interleukin-8; Mycophenolic Acid; NF-kappa B; Oxidoreductases; Proteomics; Ribavirin; SARS-CoV-2; Viral Nonstructural Proteins	2022
Effects of the 5'-Triphosphate Metabolites of Ribavirin, Sofosbuvir, Vidarabine, and Molnupiravir on CTP Synthase Catalysis and Filament Formation: Implications for Repurposing Antiviral Agents against SARS-CoV-2. ChemMedChem, 2022, 12-05, Volume: 17, Issue:23 Topics: Antiviral Agents; COVID-19; Cytidine; Escherichia coli; Humans; Ribavirin; SARS-CoV-2; Sofosbuvir; Vidarabine	2022
Ribavirin aerosol in hospitalized adults with respiratory distress and COVID-19: An open-label trial. Clinical and translational science, 2023, Volume: 16, Issue:1 Topics: Adult; COVID-19; Female; Humans; Male; Middle Aged; Respiratory Aerosols and Droplets; Respiratory Distress Syndrome; Ribavirin; SARS-CoV-2; Treatment Outcome	2023
Atypical Mutational Spectrum of SARS-CoV-2 Replicating in the Presence of Ribavirin. Antimicrobial agents and chemotherapy, 2023, 01-24, Volume: 67, Issue:1 Topics: Animals; Antiviral Agents; Chlorocebus aethiops; COVID-19; Mutagens; Mutation; Ribavirin; SARS-CoV-2; Vero Cells	2023
The photolytic behavior of COVID-19 antivirals ribavirin in natural waters and the increased environmental risk. Journal of hazardous materials, 2023, 06-15, Volume: 452 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; COVID-19; Humans; Photolysis; Ribavirin; Water; Water Pollutants, Chemical	2023
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life sciences, 2020, May-01, Volume: 248 Topics: Adenosine Monophosphate; Alanine; Alphacoronavirus; Amino Acid Sequence; Antiviral Agents; Betacoronavirus; Catalytic Domain; Computational Biology; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Guanosine Monophosphate; Guanosine Triphosphate; Humans; Molecular Docking Simulation; Pneumonia, Viral; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Ribavirin; RNA-Dependent RNA Polymerase; SARS-CoV-2; Sequence Alignment; Sequence Homology, Amino Acid; Sofosbuvir; Thermodynamics; Uridine Triphosphate; Viral Proteins	2020
Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia. Journal of medical virology, 2020, Volume: 92, Issue:7 Topics: Ascorbic Acid; Betacoronavirus; Biomarkers; Ceftriaxone; Child; China; Clinical Laboratory Techniques; Convalescence; Coronavirus Infections; COVID-19; COVID-19 Testing; Drugs, Chinese Herbal; Feces; Humans; Interferons; Male; Pandemics; Patient Discharge; Pharynx; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; SARS-CoV-2; Tomography, X-Ray Computed	2020
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral research, 2020, Volume: 178 Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antimetabolites; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Emetine; Epithelial Cells; Homoharringtonine; Humans; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; SARS-CoV-2; Vero Cells; Virus Replication	2020
Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. The British journal of ophthalmology, 2020, Volume: 104, Issue:6 Topics: Adult; Antiviral Agents; Betacoronavirus; Conjunctivitis, Viral; Coronavirus Infections; COVID-19; Humans; Male; Nasal Cavity; Ophthalmic Solutions; Pandemics; Pharynx; Pneumonia, Viral; Ribavirin; RNA, Viral; SARS-CoV-2; Treatment Outcome	2020
Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2020, Volume: 53, Issue:3 Topics: Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Drug Combinations; Female; Humans; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Ribavirin; Ritonavir; SARS-CoV-2; Taiwan; Virus Shedding	2020
Discontinuation of antiviral drugs may be the reason for recovered COVID-19 patients testing positive again. British journal of hospital medicine (London, England : 2005), 2020, Apr-02, Volume: 81, Issue:4 Topics: Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug Combinations; Female; Humans; Lopinavir; Middle Aged; Pandemics; Patient Discharge; Pneumonia, Viral; Ribavirin; Ritonavir; RNA, Viral; SARS-CoV-2	2020
Presumed COVID-19 index case on diamond princess cruise ship and evacuees to Hong Kong. Journal of travel medicine, 2020, Aug-20, Volume: 27, Issue:5 Topics: Aged, 80 and over; Betacoronavirus; Coronavirus Infections; COVID-19; Hong Kong; Humans; Japan; Lopinavir; Male; Pandemics; Pneumonia, Viral; Ribavirin; Ritonavir; SARS-CoV-2; Ships; Travel	2020
Interferon beta-1b for COVID-19. Lancet (London, England), 2020, 05-30, Volume: 395, Issue:10238 Topics: Adjuvants, Immunologic; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Interferon beta-1b; Lopinavir; Multiple Sclerosis; Pandemics; Pneumonia, Viral; Ribavirin; Ritonavir; SARS-CoV-2	2020
Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2020, Volume: 128 Topics: Adolescent; Antiviral Agents; Betacoronavirus; Child; Child, Preschool; China; Coronavirus Infections; COVID-19; Disease Susceptibility; Female; Hospitals, Pediatric; Humans; Infant; Interferon-alpha; Length of Stay; Male; Pandemics; Pediatricians; Pneumonia, Viral; Proportional Hazards Models; Retrospective Studies; Ribavirin; SARS-CoV-2; Severity of Illness Index	2020
SARS-CoV-2 persisted in lung tissue despite disappearance in other clinical samples. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:10 Topics: Aged; Antiviral Agents; Betacoronavirus; Blood Loss, Surgical; Blood Volume; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Extracorporeal Membrane Oxygenation; Fatal Outcome; Humans; Hypertension; Lung; Lung Transplantation; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Respiration, Artificial; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; SARS-CoV-2; Severity of Illness Index; Tomography, X-Ray Computed; Virus Shedding	2020
The novel coronavirus disease (COVID-19) complicated by pulmonary embolism and acute respiratory distress syndrome. Journal of medical virology, 2020, Volume: 92, Issue:10 Topics: Acute Disease; Aged; Biomarkers; Blood Platelets; Ceftazidime; COVID-19; COVID-19 Drug Treatment; Dyspnea; Fibrin Fibrinogen Degradation Products; Heparin; Humans; Hypoxia; Lung; Male; Methylprednisolone; Middle Aged; Pulmonary Embolism; Respiratory Distress Syndrome; Ribavirin; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome	2020
COVID-19 presenting with diarrhoea and hyponatraemia. BMJ case reports, 2020, Jun-07, Volume: 13, Issue:6 Topics: Abdominal Pain; Adult; Antimalarials; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Darunavir; Diagnosis, Differential; Diarrhea; Humans; Hyponatremia; Male; Pandemics; Pneumonia, Viral; Ribavirin; SARS-CoV-2; Treatment Outcome	2020
Clinical Analysis of 25 COVID-19 Infections in Children. The Pediatric infectious disease journal, 2020, Volume: 39, Issue:7 Topics: Adolescent; Age Factors; Antiviral Agents; Betacoronavirus; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Child; Child, Preschool; China; Coronavirus Infections; Cough; COVID-19; Female; Fever; Humans; Infant; Lopinavir; Lymphocyte Count; Male; Pandemics; Pneumonia, Viral; Prognosis; Retrospective Studies; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome	2020
Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19. Gut, 2021, Volume: 70, Issue:4 Topics: Adrenal Cortex Hormones; Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Hong Kong; Hospitalization; Humans; Liver; Liver Function Tests; Lopinavir; Male; Retrospective Studies; Ribavirin; Ritonavir; SARS-CoV-2; Severity of Illness Index	2021
Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19). Pathogens and disease, 2020, 06-01, Volume: 78, Issue:4 Topics: Antiviral Agents; Betacoronavirus; Bronchoalveolar Lavage Fluid; Cell Degranulation; Coronavirus Infections; COVID-19; Drug Repositioning; Endocytosis; Gene Expression Profiling; Humans; Lysosomes; Molecular Docking Simulation; Neutrophil Activation; Pandemics; Pneumonia, Viral; Ribavirin; Saquinavir; SARS-CoV-2; Transcriptome	2020
Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking. Journal of nanoscience and nanotechnology, 2020, 12-01, Volume: 20, Issue:12 Topics: Adenine; Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Binding Sites; Chloroquine; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Drug Interactions; Humans; Hydrogen Bonding; Hydroxychloroquine; Ligands; Molecular Docking Simulation; Nanotechnology; Pandemics; Pneumonia, Viral; Protease Inhibitors; Pyrazines; Pyrrolidines; Ribavirin; SARS-CoV-2; Static Electricity; Viral Nonstructural Proteins	2020
Ribavirin therapy for severe COVID-19: a retrospective cohort study. International journal of antimicrobial agents, 2020, Volume: 56, Issue:3 Topics: Adrenal Cortex Hormones; Aged; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Immunoglobulins; Male; Middle Aged; Pandemics; Patient Discharge; Pneumonia, Viral; Retrospective Studies; Ribavirin; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome	2020
Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:1 Topics: Aftercare; COVID-19; COVID-19 Drug Treatment; Female; Hospitalization; Humans; Lopinavir; Middle Aged; Patient Discharge; Recurrence; Ribavirin; RNA, Viral; SARS-CoV-2; Thorax; Virus Shedding	2021
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19. The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:4 Topics: Antiviral Agents; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Drug Combinations; Drug Repositioning; Drug Therapy, Combination; Epidemiologic Research Design; Humans; Interferon beta-1b; Lopinavir; Pandemics; Pneumonia, Viral; Ribavirin; Ritonavir; SARS-CoV-2	2020
SARS-CoV-2 viral clearance during bone marrow aplasia after allogeneic hematopoietic stem cell transplantation-A case report. Pediatric transplantation, 2021, Volume: 25, Issue:5 Topics: Anemia, Aplastic; Bone Marrow; Child; COVID-19; COVID-19 Drug Treatment; Female; Hematopoietic Stem Cell Transplantation; Humans; Metapneumovirus; Pneumonia, Viral; Postoperative Period; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; SARS-CoV-2; Transplantation, Homologous	2021
Assessment of the efficacy and safety of Ribavirin in treatment of coronavirus-related pneumonia (SARS, MERS and COVID-19): A protocol for systematic review and meta-analysis. Medicine, 2020, Sep-18, Volume: 99, Issue:38 Topics: Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Meta-Analysis as Topic; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; Research Design; Ribavirin; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Systematic Reviews as Topic; Treatment Outcome	2020
Assessment of the Potential Adverse Events Related to Ribavirin-Interferon Combination for Novel Coronavirus Therapy. Computational and mathematical methods in medicine, 2020, Volume: 2020 Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Algorithms; Bayes Theorem; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Data Mining; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Interferons; Male; Middle Aged; Neural Networks, Computer; Odds Ratio; Pandemics; Patient Safety; Pneumonia, Viral; Ribavirin; Young Adult	2020
Early triple antiviral therapy for COVID-19. Lancet (London, England), 2020, 11-07, Volume: 396, Issue:10261 Topics: Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Interferon beta-1b; Lopinavir; Pandemics; Pneumonia, Viral; Ribavirin; Ritonavir; SARS-CoV-2	2020
Early triple antiviral therapy for COVID-19 - Authors' reply. Lancet (London, England), 2020, 11-07, Volume: 396, Issue:10261 Topics: Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Interferon beta-1b; Lopinavir; Pandemics; Pneumonia, Viral; Ribavirin; Ritonavir; SARS-CoV-2	2020
The index case of COVID-19 in Northeastern Iran. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2020, Dec-03, Volume: 90, Issue:4 Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; Contact Tracing; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Humans; Iran; Male; Quarantine; Respiratory Distress Syndrome; Ribavirin; SARS-CoV-2; Tomography, X-Ray Computed; Travel-Related Illness; Treatment Outcome; Vancomycin	2020
Broadly Active Antiviral Compounds Disturb Zika Virus Progeny Release Rescuing Virus-Induced Toxicity in Brain Organoids. Viruses, 2020, 12-29, Volume: 13, Issue:1 Topics: Animals; Antiviral Agents; Brain; Cell Survival; COVID-19; Humans; Organoids; Ribavirin; RNA Viruses; SARS-CoV-2; Zika Virus; Zika Virus Infection	2020
Efficacy of ribavirin and interferon-α therapy for hospitalized patients with COVID-19: A multicenter, retrospective cohort study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 104 Topics: Adult; Aged; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Female; Humans; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; SARS-CoV-2	2021
[RNA polymerase: The Achilles heel of SARS-CoV-2]. Medecine sciences : M/S, 2021, Volume: 37, Issue:3 Topics: Antimetabolites; Antiviral Agents; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Humans; Molecular Targeted Therapy; Ribavirin; RNA-Dependent RNA Polymerase; RNA, Viral; SARS-CoV-2; Virus Replication	2021
Successful treatment of positive-sense RNA virus coinfection with autoimmune hepatitis using double filtration plasmapheresis. BMJ case reports, 2021, Mar-25, Volume: 14, Issue:3 Topics: Antiviral Agents; Coinfection; COVID-19; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Interferon alpha-2; Middle Aged; Plasmapheresis; Polyethylene Glycols; Positive-Strand RNA Viruses; Ribavirin; SARS-CoV-2; Treatment Outcome; Viral Load	2021
Different incidences of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without non-azithromycin antibiotics: A retrospective study. Journal of medical virology, 2021, Volume: 93, Issue:7 Topics: Acute Kidney Injury; Adult; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Coinfection; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Combinations; Female; Hospital Mortality; Hospitalization; Humans; Iran; Linezolid; Lopinavir; Male; Middle Aged; Retrospective Studies; Ribavirin; Ritonavir; SARS-CoV-2; Treatment Outcome; Vancomycin	2021